Company Announcements Pall acquired GeneSystems, a provider of microbiological detection systems for process monitoring, in September. Invitrogen launched a patent-licensing program in September. New England Biolabs, QIAGEN GmbH and Kirkegaard & Perry Laboratories licensed technology covering the random prime amplification of nucleic acids. Takara Bio granted Promega a license to make, use and sell LA-PCR–related […]
One of the more exciting developments in technology for life science research has been the adoption of medical imaging technologies for use with research animals. The ability to image animals in vivo not only reduces the need to sacrifice animals, but also enhances the information obtained from animal studies by allowing a researcher to follow […]
Company Announcements ScienceServe GmbH agreed to allow Advanced Chemistry Development to regain the right to directly manage sales and support in Germany, Austria and Switzerland. CLC bio became an Illumina Connect partner. CLC bio signed a strategic collaboration agreement with the J. Craig Venter Institute, which includes a multiyear site license. Ariadne Genomics named World […]
Company Announcements GENEART AG extended its strategic collaboration with QIAGEN NV to include synthetic human genes optimized for use in insect or mammalian cells in addition to those designed for production in E.coli bacteria. GENEART AG established a subsidiary on the US West Coast in San Francisco, California. Invitrogen named Joe Beery as head of […]
Company Announcements Agilent granted imaGenes GmbH the status of Certified Service Provider for Expression Profiling Services. Agilent named Turku Center for Biotechnology of University of Turku and Abo Akademi University a Certified Service Provider for gene expression microarrays. Affymetrix entered into a distribution agreement for Biotique Systems’ XRAY gene expression analysis software. Under a collaboration […]
Sydney, Australia 10/14/08 and 10/30/08—Fluorotechnics, a manufacturer of fluorescence and electrophoresis consumables and tools, raised AUD$7.6 million ($4.9 million) in its IPO (see IBO 9/15/08). The company listed shares on the Australian Stock Exchange on October 31 at a price of AUD$1 ($0.68) per share for a market capitalization of nearly AUD$25 million ($16.9 million).
Company Announcements Syrris established a subsidiary office in Japan earlier this year. In September, Prosonix, a provider of ultrasonic process chemistry solutions, announced a marketing partnership with Syrris for Prosonix’s Sonolab lab-scale equipment, which employs a transducer-based design. ThalesNano announced in September the closing of an investment of $3.3 million. In October, Micronit Microfluidics, FutureChemistry […]
Company Announcements Invitrogen and the International Regulome Consortium will codevelop tools for stem cell research. Promega will develop fluorescent ligands for its HaloTag fusion proteins to be used with Leica’s TCS stimulated emission depletion super-resolution microscope. Under an exclusive license with the University of Georgia Research Foundation, ArunA Biomedical will commercialize human mesenchymal cells derived […]
Company Announcements Accelerated Technology Laboratories partnered with Linko Data Systems, a provider of compliance-tracking software, to integrate their respective Sample Master Pro LIMS and pretreatment software for wastewater clients. Waters and LabKey Software, a provider of open source software, joined the BioIT Alliance in September. In September, Thermo Fisher Scientific began shipping its Proteome Discoverer […]
Company Announcements During fiscal year 2008, Applied Biosystems discontinued the manufacture of the 433A Peptide Synthesis and the Procise Protein Sequencing systems, but will continue to provide support for existing systems for five years. Oxford Nanopore Technologies announced in August an exclusive agreement to develop and commercialize nanopore technologies developed at Harvard University, the University […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
